LFLT Insider Trading Activity and SEC Form 4 Filings
LFLT insider trading summary
No open-market insider purchases or sales of Lifeline Therapeutics, Inc. (LFLT) have been reported on SEC Form 4 in the past 12 months.
Latest LFLT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 23, 2006 | John Van Heuvelen | Director | Buy | $140K (80,000 @ $1.75) |
| Jul 6, 2005 | James D Crapo | Director | Buy | $748K (550,000 @ $1.36) |
| Jul 6, 2005 | Paul Robert Myhill | VP, Treasurer, Secretary, CFO | Sell | $748K (550,000 @ $1.36) |
| May 16, 2005 | H Leigh Severance | Director | Buy | $25K (12,500 @ $2.00) |
| May 16, 2005 | James D Crapo | Director | Buy | $50K (25,000 @ $2.00) |
| May 16, 2005 | Javier Baz | Director | Buy | $686K (342,814 @ $2.00) |
| May 16, 2005 | H Leigh Severance | Director | Buy | $25K (12,500 @ $2.00) |
| May 15, 2005 | James Krejci | Director | Buy | $50K (25,000 @ $2.00) |
| Apr 18, 2005 | John Van Heuvelen | Director | Buy | $31K (15,264 @ $2.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.